Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019;62(4):196-202.
doi: 10.1159/000500026. Epub 2019 Jul 30.

Pathophysiology of Diabetic Retinopathy: Contribution and Limitations of Laboratory Research

Timothy S Kern  1   2 , David A Antonetti  3 , Lois E H Smith  4
Affiliations
Review

Pathophysiology of Diabetic Retinopathy: Contribution and Limitations of Laboratory Research

Timothy S Kern et al. Ophthalmic Res. 2019.

Abstract

Preclinical models of diabetic retinopathy are indispensable in the drug discovery and development of new therapies. They are, however, imperfect facsimiles of diabetic retinopathy in humans. This chapter discusses the advantages, limitations, and physiological and pathological relevance of preclinical models of diabetic retinopathy. The judicious interpretation and extrapolation of data derived from these models to humans and a correspondingly greater emphasis placed on translational medical research in early-stage clinical trials are essential to more successfully inhibit the development and progression of diabetic retinopathy in the future.

Keywords: Diabetic retinopathy; Laboratory research; Preclinical models.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST STATEMENT: The authors have no conflicts of interest to declare.

Figures

Fig 1.
Fig 1.
Vascular histopathology of diabetic retinopathy progression is similar between species, differing mainly in the severity of the retinopathy that they develop (likely due at least in part to differences in life span). Diabetic patients can develop substantial microvascular pathology, including microaneurysms and degenerate capillaries, and in some cases, pre-retinal neovascularization. Similar lesions develop in large animal models of diabetic retinopathy, except that they have not been observed to develop pre-retinal neovascularization in the 5+ years of diabetes that they have been studied. Rodents develop predominantly only degenerate capillaries (large arrow) and pericyte ghosts (small arrow) and basement membrane thickening (not shown) in their limited lifetime. The duration of time needed for the various stages of the retinopathy in the different species are indicated in parentheses.
See this image and copyright information in PMC

References

    1. Engerman RL, Bloodworth JMB Jr: Experimental diabetic retinopathy in dogs. Archives of ophthalmology 1965;73:205–210. - PubMed
    1. Engerman RL: Animal models of diabetic retinopathy. Trans Am Acad Ophthalmol Otolaryngol 1976;81:710–715. - PubMed
    1. Zheng L, Kern T: In vivo animal models of diabetic retinopathy; in HP H, M P (eds): Experimental Approaches to Diabetic Retinopathy. Basel, Karger, 2010, pp 42–60.
    1. Hatchell DL, Braun RD, Lutty GA, McLeod DS, Toth CA: Progression of diabetic retinopathy in a cat. Invest Ophthalmol Vis Sci 1995;36:S1067.
    1. Kim SY, Johnson MA, McLeod DS, Alexander T, Hansen BC, Lutty GA: Neutrophils are associated with capillary closure in spontaneously diabetic monkey retinas. Diabetes 2005;54:1534–1542. - PubMed